# IGF-1 LR3 vs HGH: Dosing, Use Cases, and Safety Monitoring
IGF-1 LR3 and HGH (somatropin) are frequently discussed together, but they are not interchangeable. HGH works upstream through growth hormone receptor signaling and downstream IGF-1 production. IGF-1 LR3 works more directly at the IGF-1 receptor with longer free exposure than native IGF-1.
If you are choosing between them, the decision is less about hype and more about objective goals, tolerance, monitoring discipline, and cycle structure.
Quick Comparison
| Factor | IGF-1 LR3 | HGH (Somatropin) |
|---|---|---|
| Primary pathway | Direct IGF-1 receptor activity | Growth hormone receptor, then IGF-1 axis |
| Typical half-life | ~20-30 hours | ~2-3 hours plasma (longer biologic effects) |
| Typical protocol style | Shorter, targeted cycles | Longer endocrine protocols |
| Common use context | Recomposition, recovery blocks | Clinical GHD, body comp, recovery |
| Regulatory status | Research only (US) | FDA-approved for specific indications |
Mechanism Differences That Matter
HGH (Somatropin)
HGH increases circulating IGF-1 and affects:
- Lipolysis and body composition
- Connective tissue remodeling
- Recovery and sleep architecture in some users
- Broader endocrine adaptation over time
Because HGH is upstream, effects can be more systemic and slower to stabilize.
IGF-1 LR3
IGF-1 LR3 is engineered for lower binding to IGF-binding proteins (IGFBPs), leading to:
- Longer active window
- Direct anabolic and recovery signaling
- Higher sensitivity to dose escalation errors
Because it sits further downstream, protocol response can feel more acute but can also carry sharper glucose-management considerations.
Dosing Frameworks (Educational Reference)
IGF-1 LR3
- Conservative: 20 mcg/day
- Standard: 40-80 mcg/day
- Advanced short block: 80-120 mcg/day
- Pattern: Often 4-8 week block, then washout
HGH (Somatropin)
- Wellness/anti-aging context: 1-2 IU/day
- Body composition context: 2-4 IU/day
- Advanced short-term context: 4-6 IU/day
- Pattern: Often 3-6 month programs when medically supervised
These are not prescribing recommendations and should not replace clinician-directed dosing.
Reconstitution and Unit Clarity
One frequent source of errors is unit mismatch:
- IGF-1 LR3 is commonly discussed in mcg
- HGH is commonly discussed in IU (or mg in clinical labeling)
Never copy a protocol without confirming unit conversion and vial concentration.
Safety and Monitoring Checklist
For either route, track objective data:
- Fasting glucose and/or A1c
- IGF-1 labs
- Blood pressure
- Fluid retention/edema
- Joint discomfort or carpal tunnel-like symptoms
- Sleep quality and recovery markers
If stacking GH-axis compounds, increase lab frequency and lower starting doses.
Stacking Context
Common stacks discussed in advanced circles include:
- HGH + IGF-1 LR3
- HGH + CJC-1295/Ipamorelin
- IGF-1 LR3 + GH secretagogues
Stacking can increase both upside and risk. Most protocol failures come from aggressive starts, not lack of compounds.
Which One Fits Better?
Use-case framing:
- Need broad endocrine support over months? HGH is usually the base discussion.
- Need a shorter targeted anabolic/recovery block? IGF-1 LR3 is often the candidate.
- Need medical legitimacy and approved-label pathways? HGH has the stronger clinical footing.
The best protocol is the one you can monitor, tolerate, and execute consistently.
FAQ
Q: Is IGF-1 LR3 stronger than HGH?
A: They are different tools. IGF-1 LR3 can feel more direct because it acts downstream at IGF-1 receptors, while HGH creates broader endocrine changes upstream.
Q: Can you run IGF-1 LR3 and HGH together?
A: Some advanced protocols do, but overlap increases complexity and risk. If combined, conservative dosing and frequent labs are essential.
Q: Why does HGH use IU and IGF-1 LR3 use mcg?
A: HGH is biologic-activity standardized in IU, while IGF-1 LR3 protocols are typically mass-based in micrograms.
Q: What is the biggest safety mistake?
A: Escalating too fast without glucose and IGF-1 monitoring.
---
PeptIQ helps you track compounds, cycle length, dose history, and response signals so decisions are based on data rather than guesswork.
